Back to video list Back to Home If optimizing the dose of the current antidepressant is not an effective strategy, at which part of the dose range can we consider adding an augmenting agent? You may also like Brain Health Article Neuronal growth and plasticity is focus of top brain prize Schizophrenia Satellite symposium Article Targeting trace amine-associated receptors (TAARs) to treat schizophrenia Parkinson's Disease Article Approaches for better management of Parkinson’s disease Depression Anxiety Satellite symposium Article Improving functioning as a treatment goal in comorbid major depressive disorder and generalized anxiety disorder